Biotechnology in China

Biotechnology in China


  • Products Id :- OHME7982
  • |
  • Pages: 33
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China

Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts

Reasons To Buy

What was the size of the China biotechnology market by value in 2016?

What will be the size of the China biotechnology market in 2021?

What factors are affecting the strength of competition in the China biotechnology market?

How has the market performed over the last five years?

What are the main segments that make up China's biotechnology market?

Key Highlights

The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

The Chinese biotechnology market is expected to generate total revenues of $18.5bn in 2016, representing a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016.

The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $18.1bn, equivalent to 97.8% of the market's overall value.

The Chinese government is seeking to help the domestic biotechnology industry through the creation of biotech zones and preferential regulations to locally produced drugs. It is hoped this will move Chinese companies away from cheap, generic drugs.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Executive Summary

Market value

Market value forecast

Category segmentation

Geography segmentation

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Category segmentation

Geography segmentation

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Novo Nordisk A/S

Shanghai Kehua Bio-engineering Co., Ltd

Sinovac Biotech Ltd.

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine

Figure 1: China biotechnology industry value: $ million, 2012-16(e)

Figure 2: China biotechnology industry category segmentation: % share, by value, 2016(e)

Figure 3: China biotechnology industry geography segmentation: % share, by value, 2016(e)

Figure 4: China biotechnology industry value forecast: $ million, 2016-21

Figure 5: Forces driving competition in the biotechnology industry in China, 2016

Figure 6: Drivers of buyer power in the biotechnology industry in China, 2016

Figure 7: Drivers of supplier power in the biotechnology industry in China, 2016

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2016

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2016

Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2016

Figure 11: Novo Nordisk A/S: revenues & profitability

Figure 12: Novo Nordisk A/S: assets & liabilities

Figure 13: Shanghai Kehua Bio-engineering Co., Ltd: revenues & profitability

Figure 14: Shanghai Kehua Bio-engineering Co., Ltd: assets & liabilities

Figure 15: Sinovac Biotech Ltd.: revenues & profitability

Figure 16: Sinovac Biotech Ltd.: assets & liabilities

Table 1: China biotechnology industry value: $ million, 2012-16(e)

Table 2: China biotechnology industry category segmentation: $ million, 2016(e)

Table 3: China biotechnology industry geography segmentation: $ billion, 2016(e)

Table 4: China biotechnology industry value forecast: $ million, 2016-21

Table 5: Novo Nordisk A/S: key facts

Table 6: Novo Nordisk A/S: key financials ($)

Table 7: Novo Nordisk A/S: key financials (DKK)

Table 8: Novo Nordisk A/S: key financial ratios

Table 9: Shanghai Kehua Bio-engineering Co., Ltd: key facts

Table 10: Shanghai Kehua Bio-engineering Co., Ltd: key financials ($)

Table 11: Shanghai Kehua Bio-engineering Co., Ltd: key financials (CNY)

Table 12: Shanghai Kehua Bio-engineering Co., Ltd: key financial ratios

Table 13: Sinovac Biotech Ltd.: key facts

Table 14: Sinovac Biotech Ltd.: key financials ($)

Table 15: Sinovac Biotech Ltd.: key financial ratios

Table 16: China size of population (million), 2012-16

Table 17: China gdp (constant 2005 prices, $ billion), 2012-16

Table 18: China gdp (current prices, $ billion), 2012-16

Table 19: China inflation, 2012-16

Table 20: China consumer price index (absolute), 2012-16

Table 21: China exchange rate, 2012-16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novo Nordisk A/S Shanghai Kehua Bio-engineering Co., Ltd Sinovac Biotech Ltd.

Biotechnology, MarketLine, China

select a license

Single User License
USD 350 INR 22673
Site License
USD 700 INR 45346
Corporate User License
USD 1050 INR 68019

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com